| Application no. and date | 17173501.2 (espacenet) (Federated) (European Patent Register), 20110202 | | Patent/reg. no. and date | DK/EP 3275896, 20210616 | | Publication date | 20180131 | | Priority no. and date | GB 201001791, 20100203 | | EP pub. no. and date |
EP 3275896 20180131 | | Effective date | | | Applicant/owner | UCB Biopharma SRL, Allée de la Recherche 60
1070 Brussels, BE | | Applicant ref. no. | 164831 | | Inventor | Bilgischer, Jean-Pascal Pierre, c/o UCB Pharma, IP Department
60 Allée de la Recherche
1070 Brussels, BE,
Bassett, Philip Jonathan, c/o UCB Celltech, IP department
208 Bath Road
Slough, Berkshire SL1 3WE, GB,
Pearce-Higgins, Mark Robert, c/o UCB Celltech, IP department
208 Bath Road
Slough, Berkshire SL1 3WE, GB,
Kenny, Andrew John, 21 Beechwood Road
Fishburn, Stockton-on-Tees TS21 4EP, GB | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | C07K 16/00 (2006.01) | | Title | FREMGANGSMÅDE TIL AT OPNÅ ANTISTOFFER | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
